The French are not happy about Gilead's pricing and they intend to do something about it.  "The government will selectively tax drugmakers when the total cost to the state from their hepatitis C drugs exceeds a certain amount each year, "

http://hepatitiscnewdrugs.blogspot.com/20l4/09/france-uses-tax-to-put-pressure-on.html

I'm liking the sound of this.

Take that, Pharma.